SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-042067
Filing Date
2017-06-27
Accepted
2017-06-27 21:53:06
Documents
2
Period of Report
2017-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 1564
2 EX-24 DOCUMENT attachment1.htm EX-24 1713
  Complete submission text file 0001209191-17-042067.txt   4717
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5425 WISCONSIN AVENUE SUITE 800 CHEVY CHASE MD 20815
Business Address
Nayeem Sara M. (Reporting) CIK: 0001709110 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38129 | Film No.: 17933625